Your browser doesn't support javascript.
loading
Comparison of risk assessment tools for cardiovascular diseases: results of an Iranian cohort study.
Motamed, N; Ajdarkosh, H; Perumal, D; Ashrafi, G H; Maadi, M; Safarnezhad Tameshkel, F; Farahani, B; Rezaie, N; Nikkhah, M; Faraji, A H; Miri, S M; Roozafzai, F; Khoonsari, M; Karbalaie Niya, M H; Zamani, F.
Afiliação
  • Motamed N; Department of Social Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Ajdarkosh H; Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Perumal D; Faculty of Science, Engineering and Computing, Kingston University, Kingston, United Kingdom.
  • Ashrafi GH; Cancer Theme SEC Faculty Penrhyn Road, Kingston University London, KT1 2EE, United Kingdom.
  • Maadi M; Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Safarnezhad Tameshkel F; Student Research Committee, Iran University of Medical Sciences, Tehran, Iran; Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Farahani B; Department of Cardiology, Iran University of Medical Sciences, Tehran, Iran.
  • Rezaie N; Department of Pulmonology, Firouzgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Nikkhah M; Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Faraji AH; Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Miri SM; Nedmedica, Heerlen, Netherlands.
  • Roozafzai F; Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran; Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Khoonsari M; Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Karbalaie Niya MH; Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Zamani F; Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran. Electronic address: Zamani.f@iums.ac.ir.
Public Health ; 200: 116-123, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34717165
ABSTRACT

OBJECTIVES:

Several popular cardiovascular risk assessment tools have been developed in Western countries; however, the predictive abilities of these tools have not been evaluated in Middle Eastern countries. The present study aimed to determine the abilities of cardiovascular risk assessment tools in a population-based study in Northern Iran. STUDY

DESIGN:

Population-based cohort study in Northern Iran.

METHODS:

In total, 2883 individuals (1629 men and 1254 women), aged 40-74 years, were included in the study. We determined the predictive abilities of the American College of Cardiology/American Heart Association (ACC/AHA) risk prediction tool, the Framingham general cardiovascular risk profile in primary care settings, and the Systematic Coronary Risk Evaluation (SCORE) equations for low- and high-risk European countries. Receiver operating characteristic (ROC) analysis was used to determine the predictive abilities of these four risk assessment tools.

RESULTS:

Based on areas under curve (AUC) values and related 95% confidence intervals (95% CIs), the discriminative abilities of the ACC/AHA tool, the Framingham approach, and the SCORE for low- and high-risk European countries to estimate non-fatal cardiovascular disease (CVD) events were 0.6625, 0.6517, 0.6476 and 0.6458, respectively, in men, and 0.7722, 0.7525, 0.7330 and 0.7331, respectively, in women. Moreover, the abilities of these four tools to estimate fatal CVD events were found to be 0.8614, 0.8329, 0.7996 and 0.7988 in men, and 0.8779, 0.8372, 0.8535 and 0.8518 in women, respectively.

CONCLUSIONS:

The cardiovascular risk assessment tools investigated in this study showed acceptable predictive abilities in women. The ACC/AHA approach showed slightly better performance compared with the SCORE tool; however, the SCORE tool benefited from the lowest cost compared with all the other tools.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male País como assunto: America do norte / Asia / Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male País como assunto: America do norte / Asia / Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article